Literature DB >> 17687534

[Headache and migraine].

H C Diener1, M A Slomke, V Limmroth.   

Abstract

Headaches are one of the most common disorders and symptoms in daily medical practice. There has been dramatic progress of knowledge in the fields of epidemiology, pathophysiology, acute treatment, and preventive therapy over the past 100 years. Triptans have been the breakthrough in the treatment of acute migraine attacks. Beta blockers, calcium antagonists, and neuromodulators are available for preventive migraine therapy. Treatment for chronic tension headache is still unsatisfying. Cluster headache is part of the group of trigemino-autonomic headaches. Headache from medication overuse plays an increasingly important role. New medical care structures such as integrated headache care provide better support for patients with chronic headache disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687534     DOI: 10.1007/s00115-007-2332-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  56 in total

1.  Perfusion weighted imaging during migraine: spontaneous visual aura and headache.

Authors:  M Sanchez del Rio; D Bakker; O Wu; R Agosti; D D Mitsikostas; L Ostergaard; W A Wells; B R Rosen; G Sorensen; M A Moskowitz; F M Cutrer
Journal:  Cephalalgia       Date:  1999-10       Impact factor: 6.292

2.  Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.

Authors:  E A MacGregor; A Frith; J Ellis; L Aspinall; A Hackshaw
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

3.  The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study.

Authors:  H C Diener; V Pfaffenrath; L Pageler; H Peil; B Aicher
Journal:  Cephalalgia       Date:  2005-10       Impact factor: 6.292

Review 4.  Comorbidity of migraine.

Authors:  Ann I Scher; Marcelo E Bigal; Richard B Lipton
Journal:  Curr Opin Neurol       Date:  2005-06       Impact factor: 5.710

5.  Obesity is a risk factor for transformed migraine but not chronic tension-type headache.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

6.  Topiramate in the treatment of chronic migraine.

Authors:  M Silvestrini; M Bartolini; M Coccia; R Baruffaldi; R Taffi; L Provinciali
Journal:  Cephalalgia       Date:  2003-10       Impact factor: 6.292

7.  Epidemiology of chronic daily headache.

Authors:  I Kavuk; A Yavuz; U Cetindere; M W Agelink; H C Diener
Journal:  Eur J Med Res       Date:  2003-06-30       Impact factor: 2.175

Review 8.  Medication-overuse headache: a worldwide problem.

Authors:  Hans-Christoph Diener; Volker Limmroth
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

9.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

10.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292

View more
  1 in total

1.  Alleviation of migraine symptoms by application of repetitive peripheral magnetic stimulation to myofascial trigger points of neck and shoulder muscles - A randomized trial.

Authors:  Tabea Renner; Nico Sollmann; Michaela V Bonfert; Mirjam N Landgraf; Florian Heinen; Lucia Albers; Florian Trepte-Freisleder; Birgit Klose; Helene König; Sandro M Krieg
Journal:  Sci Rep       Date:  2020-04-06       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.